Latest Global Expansion Strategy News

Evion Group gains momentum as the US-Africa Strategic Infrastructure and Investment Working Group fosters trade, Madagascar accelerates mining permits, and Indian graphite operations deliver strong sales.

Bioxyne Limited has delivered a record-breaking second quarter in FY2026, posting $17.2 million in revenue and expanding its footprint into key international markets. The company’s growth is underpinned by new contracts, innovative psychedelics products, and strategic government funding.

ALS Limited reported a robust half-year performance with underlying revenue up 13.3% and net profit after tax rising 17.2%, driven by strong growth in both Commodities and Life Sciences divisions. The company also declared a higher interim dividend and advanced its global expansion strategy.

Tungsten Mining has secured a listing on the US OTCQB exchange and launched a Denver office, marking a strategic push into North America’s critical minerals market.

Neuren Pharmaceuticals reported a milestone quarter with DAYBUE net sales reaching US$101.1 million, driving a 24% jump in royalty income. The expanding patient base and community physician uptake signal strong growth ahead.

Pureprofile Limited has reported record Q1 FY26 revenue and EBITDA growth, with international markets overtaking its traditional ANZ base for the first time. The company’s AI-driven platform innovations and global expansion strategy are driving this milestone.

Nova Eye Medical has gained regulatory approval for its iTrack Advance glaucoma device in China, setting the stage for significant market expansion and sales growth from late fiscal 2026.

EQ Resources Limited has appointed industry veteran Craig Bradshaw as Managing Director, marking a strategic leadership transition to drive growth in global tungsten mining.

Nanoveu Limited’s transformative half-year report highlights its EMASS acquisition, executive hires, and technology advances amid a $3 million loss and new US OTCQB listing.

RooLife Group has agreed to sell its Australian digital marketing subsidiary CHOOSE Digital for $356,500, marking a strategic pivot towards high-margin international product sales.

Titomic’s Netherlands division has secured €800,000 in funding from the Dutch 3D Print Kompas program to advance its Cold Spray Additive Manufacturing technology, aiming to expand R&D and industrial applications across Europe.

Proteomics International has achieved a major milestone with the first worldwide patent granted in Japan for its PromarkerEndo blood test, designed to diagnose endometriosis early and accurately.